NDA Group

Welcome to NDA Group

Europe’s leading regulatory drug development, pharmacovigilance and HTA consultancy

We support life science companies all over the world and across all phases of development, from pre-clinical to post marketing, to the needs and requirements of regulators and payers alike. We work together with our clients to address key strategic regulatory and reimbursement challenges. Our scientific expertise covers all major therapeutic areas.

The advice you get from NDA is from real experts in the industry, many who have been involved in shaping today’s regulatory, HTA and pharmacovigilance environment. We have close to 100 employees across Europe. More than 25% are ex EU regulators.

With our support, you can cut the time and associated cost it takes to get your products to market, and keep them there.

NDA supported more than 38% of the new medicinal products that were approved in the EU in 2014.

More +
and Quality
More +
Health Technology
More +
NDA Advisory
More +

Expert Spotlight

Professor Ken Paterson   |   HTA Advisory Board Member

More +
Professor Ken Paterson How Ken can help your Business

Ken can assist in developing clinical investigation programmes to meet the needs of health technology assessment (HTA) and reimbursement bodies as well as regulators, and in translating clinical trial efficacy into patient-centred clinical value. His combination of wide-ranging clinical expertise and health economic experience is unusual and allows him to offer insightful analysis and advice. This may be particularly useful where the needs of regulators and HTA are perceived to be different but may actually be reconcilable.

More +

Latest News from NDA

  • Steffen Adaptive Pathways: challenges & opportunities for Regulatory, HTA & Payers
    Welcome to breakfast seminar in our Swedish office 7th October. Hear Professor Steffen Thirstrup, Director of the NDA Re… Read more
    Pieter_Neels Dr Pieter Neels speaks at Pharmaceutical Law Workshop in Hanoi, Vietnam
    Dr Neels, NDA Group Clinical Expert and Advisory Board member, has been invited to present at Pharma Group - the Pharmac… Read more
    NLSDAYS-Logo_2015 Meet NDA at Nordic Life Science Days 9-10 September
    Nordic Life Science Days is the largest Nordic partnering conference for the global Life Science industry. Bringing toge… Read more
  • Felix Lobo Félix Lobo chairman of the 15th Spanish Pharmaceutical Industry Meeting
    Professor Lobo, NDA Advisory Board member, is organizing and chairing the 15th Spanish Pharmaceutical Industry Meeting i… Read more
    Dr Thomas Lönngren NDA's Thomas Lönngren participates in an EU-Global Regulatory workshop
    Dr. Thomas Lönngren, Strategic Advisor NDA Group, will present and participate in the session and workshop 'In Conversat… Read more
    Dr Thomas Lönngren Dr. Lönngren speaks on emerging trends in drug development at ARCS
    Dr. Thomas Lönngren, Strategic Advisor to NDA Group and former Executive Director of the European Medicines Agency (EMA)… Read more
We make sure that men, women and children all over the world get access
to the best possible medicines without unnecessary delay.